thumbnail image
HomeAbout UsDeal TeamPortfolioNewsContact Us
HomeAbout UsDeal TeamPortfolioNewsContact Us
中文
HomeAbout UsDeal TeamPortfolioNewsContact Us
HomeAbout UsDeal TeamPortfolioNewsContact Us
HomeAbout UsDeal TeamPortfolioNewsContact Us
中文
  • Home
  • About Us
  • Deal Team
  • Portfolio
  • News
  • Contact Us
    •  

       

       

      LING SU, Ph.D.

      Venture Partner

    • Ling Su, Ph.D., is a Venture Partner with Lilly Asia Ventures (LAV). Prior to joining LAV, He has over 25 years’ experience in drug regulatory and development. He had worked in various R&D management positions in the pharma industry, including Medical Director at Merck, Pharma Development Director at Roche, VP for Clinical Research Asia Pacific at Wyeth, and SVP and Head of Development China at Novartis. Prior to that, he worked in the Chinese regulatory agency and CDER, US FDA. Currently, Ling is also a professor in Regulatory Science in Shenyang Pharmaceutical University and serves as an advisor to the Chinese regulatory agency on numerous projects. He is a member of the Hong Kong Stock Exchange Biotech Advisory Panel. Ling holds B.S. in pharmacology from Shanghai Medical University, M.S. in Clinical Pharmacy and Ph.D. in Epidemiology from University of North Carolina at Chapel Hill, USA.

    Company

     

    Shanghai

    Room2909-14, 168 Hubin Road, Huangpu District, Shanghai, China.

     

     

    Hong Kong

    Unit 902-904, Two ChinaChem Central, 26 Des Voeux Road Central, Hong Kong

     

     

    US

    2730 Sand Hill Road, Suite 130, Menlo Park, CA

    copyright © 2018 Lilly Asia Ventures all rights reserved.

    沪ICP备12003647号

    沪公网安备 31010102005458号

      All Posts
      ×
      LillyAsiaVentures
      Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
      http://user-assets.sxlcdn.com/images/315509/FnksTvTDur7jpExbqYminmtjWgoM.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/format/png
      Cookie Use
      We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
      Learn More